Paradigm Biopharmaceuticals Ltd has released a press release.
Quarterly Report and Appendix 4C - quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
Paradigm Biopharmaceuticals Ltd. on 6ix
Story so far
Earlier from Paradigm Biopharmaceuticals
- Completion of Institutional Entitlement Offer
- PAR Accelerated Non-Renounceable Rights Issue Offer Booklet
- Paradigm Confirms Capital Raise Commitments
- Paradigm updated corporate presentation
- Paradigm launches a$77.9M capital raise
Later from Paradigm Biopharmaceuticals
- Paradigm Corporate Update - May 2019
- Successful Completion of Retail Entitlement Offer
- PAR corrects afr article
- PAR reports consistent pain reduction in knee OA of patients
- PAR reports successful ross river phase 2 clinical trial
Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.
Follow Paradigm Biopharmaceuticals